Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Poplin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluationJ D Roberts, E A Poplin, M B Tombes, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904K S Albain, P Y Liu, A Hantel, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancerE A Poplin, P LoRusso, J J Lokich, et al.
Cancer|August 15, 1994
Chemoradiotherapy of esophageal carcinomaE A Poplin, P S Khanuja, M J Kraut, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluationJ D Roberts, E A Poplin, M B Tombes, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904K S Albain, P Y Liu, A Hantel, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancerE A Poplin, P LoRusso, J J Lokich, et al.
Cancer|August 15, 1994
Chemoradiotherapy of esophageal carcinomaE A Poplin, P S Khanuja, M J Kraut, et al.
Pageof 2